National Institute Of Cardiovascular Diseases, Pakistan
Clinical trials sponsored by National Institute Of Cardiovascular Diseases, Pakistan, explained in plain language.
-
Heart attack drug may prevent dangerous 'No-Reflow' during artery opening
Disease control Recruiting nowThis study tests whether giving the drug adenosine before angioplasty (a procedure to open blocked heart arteries) can reduce the risk of slow or no blood flow afterward in people having a heart attack. About 1,148 adults with a specific type of heart attack (STEMI) will take par…
Phase: PHASE4 • Sponsor: National Institute of Cardiovascular Diseases, Pakistan • Aim: Disease control
Last updated May 26, 2026 12:09 UTC
-
Balloon vs. stent: could a temporary fix beat a permanent implant for young heart attack patients?
Disease control Recruiting nowThis study tests whether a drug-coated balloon (DCB) works as well as a drug-eluting stent (DES) in young adults (ages 18–50) having a severe heart attack. The balloon is temporary and leaves nothing behind, which may reduce long-term risks like blood clots and the need for prolo…
Phase: PHASE3 • Sponsor: National Institute of Cardiovascular Diseases, Pakistan • Aim: Disease control
Last updated May 19, 2026 12:00 UTC
-
10,000 people to get heart risk check in major prevention study
Knowledge-focused Recruiting nowThis study aims to better understand how to assess and reduce heart disease risk in 10,000 people. Researchers will use standard risk scores to classify participants and track outcomes. The goal is to improve prevention strategies and lower heart-related deaths.
Sponsor: National Institute of Cardiovascular Diseases, Pakistan • Aim: Knowledge-focused
Last updated May 22, 2026 13:50 UTC